ClassID:

111613

C12N2770/32734 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Picornaviridae; Rhinovirus Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Recent Application in this class:
#1
20260124291
2026-05-07

RHINOVIRUS MRNA VACCINE

#2
20250057933
2025-02-20

Rhinovirus Vaccine

#3
20230174953
2023-06-08

DEFECTIVE INTERFERING VIRAL GENOMES

#4
20190224303
2019-07-25

Human rhinovirus vaccine

#5
20190076519
2019-03-14

Immunogenic rhinovirus peptides

#6
20180064802
2018-03-08

Immunogenic Human Rhinovirus (HRV) Composition

#7
20180043006
2018-02-15

Compositions and methods for preventing and treating rhinovirus infections

#8
20170305973
2017-10-26

Rhinovirus C immunogenic peptides

#9
20160095916
2016-04-07

Induction of cross-reactive cellular response against rhinovirus antigens

#10
20160022804
2016-01-28

Immunogenic human rhinovirus (HRV) compositions

#11
20160022803
2016-01-28

Vaccine

#12
20140341923
2014-11-20

Human Rhinovirus (HRV) Antibodies

#13
20140161833
2014-06-12

Neutralizing immunogen (NimIV) of rhinovirus and its uses for vaccine applications

#14
20130052163
2013-02-28

Human rhinovirus (HRV) antibodies

#15
20120237543
2012-09-20

Equine rhinitis vaccine

#16
20120213820
2012-08-23

Method for diagnosing a rhinovirus infection

#17
20120164177
2012-06-28

RHINOVIRUS VACCINES

#18
20100297169
2010-11-25

Neutralizing immunogen (NimIV) of rhinovirus and its use for vaccine applications

#19
20100172935
2010-07-08

Method for viral inoculation of the vestibular region of the nares

#20
20090324501
2009-12-31

Vaccine carrier

#21
20090202583
2009-08-13

Rhinovirus vaccines

#22
20060088549
2006-04-27

Chimeric virus vaccine

#23
20060015969
2006-01-19

Novel immunoadhesins for treating and prventing toxicity and pathogen-mediated diseases